Market by Technology, Diagnostic Method, Product, Pathogen, Testing Type, and Country | Forecast 2021-2028
As mentioned in Triton’s
research report, the Asia-Pacific sepsis diagnostics market is estimated to witness
growth at 8.69% of CAGR during the period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries considered in
this market include:
• India
• China
• Japan
• Australia & New Zealand
• South Korea
• ASEAN countries
• Rest of Asia-Pacific
The sepsis diagnostics market
is anticipated to experience lucrative growth in the region, owing to rapid
economic development in countries such as India and China. Additionally, the
increase in mortality rate due to sepsis disease is likely to surge the demand
for sepsis diagnostics across the region in the upcoming years. Apart from
these factors, the growing awareness pertaining to sepsis diagnosis and
treatment is estimated to help counter the disease’s adverse effects, driving
the studied market’s growth across the APAC region.
Sepsis is among the leading
causes of death among patients in the ICUs across China. Moreover, sepsis
affects a fifth of patients in the ICUs with a 90-day mortality rate, as per
clinical criteria study. Besides, the mortality rate of sepsis remains high due
to a lack of epidemiological data. This indicates that severe sepsis or septic
shock represents a major disease burden within the country. Hence, there is an
urgent need to enhance the early sepsis triage system, strengthen the core skills
of clinicians, and control nosocomial infections. This rise in sepsis
prevalence is estimated to increase the demand for sepsis diagnosis, thereby
augmenting the progression of China’s sepsis diagnostics market over the next
few years.
Danaher Corporation is a
manufacturer of professional, medical, industrial, and commercial products and
services. It primarily focuses on developing applications for environmental and
applied solutions, dental care, medical diagnostics, and others. Further, the
company’s wide portfolio includes analytical instruments, reagents,
consumables, and software for medical diagnostic purposes. Danaher operates
across various regions, including Asia-Pacific, via a network of manufacturing
and distribution facilities.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
SEPSIS DIAGNOSTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON SEPSIS DIAGNOSTICS MARKET
2.2. KEY
INSIGHTS
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. CONTRACTS
AND PARTNERSHIP
2.6.2. BUSINESS
EXPANSION AND DIVESTITURES
2.6.3. ACQUISITIONS
& MERGERS
2.6.4. NEW
PRODUCT LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. RISE
IN HOSPITAL-ACQUIRED INFECTIONS AMONG PATIENTS
2.7.2. INCREASED
PREVALENCE OF SEPSIS
2.8. MARKET
RESTRAINTS
2.8.1. HIGH
COST ASSOCIATED WITH THE INSTRUMENT
2.8.2. REIMBURSEMENT
ISSUES
2.9. MARKET
OPPORTUNITIES
2.9.1. GROWTH
OPPORTUNITIES IN THE EMERGING ECONOMIES
3. ASIA-PACIFIC
SEPSIS DIAGNOSTICS MARKET - BY TECHNOLOGY
3.1. MICROBIOLOGY
3.2. IMMUNOASSAY
3.3. MOLECULAR
DIAGNOSTICS
3.4. OTHER
TECHNOLOGIES
4. ASIA-PACIFIC
SEPSIS DIAGNOSTICS MARKET - BY DIAGNOSTIC METHOD
4.1. CONVENTIONAL
DIAGNOSTICS
4.2. AUTOMATED
DIAGNOSTICS
5. ASIA-PACIFIC
SEPSIS DIAGNOSTICS MARKET - BY PRODUCT
5.1. BLOOD
CULTURE MEDIA
5.2. ASSAY
KITS & REAGENTS
5.3. INSTRUMENTS
6. ASIA-PACIFIC
SEPSIS DIAGNOSTICS MARKET - BY PATHOGEN
6.1. GRAM
- POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS
6.2. FUNGAL
SEPSIS
6.3. OTHER
PATHOGENS
7. ASIA-PACIFIC
SEPSIS DIAGNOSTICS MARKET - BY TESTING TYPE
7.1. LABORATORY
TESTING
7.2. POINT-OF-CARE
TESTING
8. ASIA-PACIFIC
SEPSIS DIAGNOSTICS MARKET – COUNTRY OUTLOOK
8.1. COUNTRY
ANALYSIS
8.1.1. CHINA
8.1.2. JAPAN
8.1.3. INDIA
8.1.4. AUSTRALIA
& NEW ZEALAND
8.1.5. SOUTH
KOREA
8.1.6. ASEAN
COUNTRIES
8.1.7. REST
OF ASIA-PACIFIC
9. COMPETITIVE
LANDSCAPE
9.1. ABBOTT
LABORATORIES
9.2. BECTON
DICKINSON AND COMPANY (CR BARD)
9.3. BIOMERIEUX
SA
9.4. BRUKER
CORPORATION
9.5. CYTOSORBENTS
9.6. DANAHER
CORPORATION
9.7. EKF
DIAGNOSTICS
9.8. F
HOFFMANN-LA ROCHE
9.9. IMMUNEXPRESS
INC
9.10. LUMINEX
CORPORATION
9.11. RESPONSE
BIOMEDICAL CORPORATION
9.12. T2
BIOSYSTEMS INC
9.13. THERMO
FISHER SCIENTIFIC INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.1.1. OBJECTIVES
OF STUDY
10.1.2. SCOPE
OF STUDY
10.2. SOURCES
OF DATA
10.2.1. PRIMARY
DATA SOURCES
10.2.2. SECONDARY
DATA SOURCES
10.3. RESEARCH
METHODOLOGY
10.3.1. EVALUATION
OF PROPOSED MARKET
10.3.2. IDENTIFICATION
OF DATA SOURCES
10.3.3. ASSESSMENT
OF MARKET DETERMINANTS
10.3.4. DATA
COLLECTION
10.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF CONTRACTS & PARTNERSHIPS
TABLE 5: LIST OF BUSINESS EXPANSIONS &
DIVESTITURES
TABLE 6: LIST OF ACQUISITIONS & MERGERS
TABLE 7: LIST OF NEW PRODUCT LAUNCHES
TABLE 8: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET,
BY DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY
PATHOGEN, 2021-2028 (IN $ MILLION)
TABLE 12: GRAM-NEGATIVE BACTERIA CAUSING SEPSIS
TABLE 13: GRAM-POSITIVE BACTERIA CAUSING SEPSIS
TABLE 14: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY
TESTING TYPE, 2021-2028 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 3: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY MICROBIOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 4: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY IMMUNOASSAY, 2021-2028 (IN $ MILLION)
FIGURE 5: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2020 & 2028 (IN %)
FIGURE 8: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY CONVENTIONAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY AUTOMATED DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 11: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY BLOOD CULTURE MEDIA, 2021-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY ASSAY KITS & REAGENTS, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY PATHOGEN, 2020 & 2028 (IN %)
FIGURE 15: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS,
2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY FUNGAL SEPSIS, 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY OTHER PATHOGENS, 2021-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY TESTING TYPE, 2020 & 2028 (IN %)
FIGURE 19: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY LABORATORY TESTING, 2021-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2021-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC SEPSIS
DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 22: CHINA SEPSIS DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: JAPAN SEPSIS DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: INDIA SEPSIS DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: AUSTRALIA & NEW
ZEALAND SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: SOUTH KOREA SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: ASEAN COUNTRIES SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: REST OF ASIA-PACIFIC
SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)